Krystal Biotech, Inc.

Historical 13F Holders

Symbol
KRYS
CUSIP
501147102
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 348 24.5 M $6.04 B
2025 Q3 306 28.3 M $4.99 B
2025 Q2 296 27.7 M $3.80 B
2025 Q1 321 27.4 M $4.94 B
2024 Q4 291 27.8 M $4.35 B
2024 Q3 310 28.4 M $5.15 B
2024 Q2 266 29.4 M $5.40 B
2024 Q1 263 26.3 M $4.68 B
2023 Q4 213 25.8 M $3.20 B
2023 Q3 208 24.5 M $2.84 B
2023 Q2 202 23.9 M $2.80 B
2023 Q1 178 21.9 M $1.76 B
2022 Q4 169 23.3 M $1.84 B
2022 Q3 162 20.9 M $1.46 B
2022 Q2 145 20.8 M $1.36 B
2022 Q1 146 20.6 M $1.37 B
2021 Q4 161 19.3 M $1.35 B
2021 Q3 133 16.3 M $851 M
2021 Q2 126 16.4 M $1.12 B
2021 Q1 123 16.5 M $1.27 B
2020 Q4 118 14.0 M $842 M
2020 Q3 106 14.4 M $623 M
2020 Q2 117 14.3 M $593 M
2020 Q1 93 11.6 M $502 M
2019 Q4 93 11.6 M $643 M
2019 Q3 89 11.5 M $400 M
2019 Q2 78 9.83 M $398 M
2019 Q1 58 6.71 M $223 M
2018 Q4 47 6.27 M $130 M
2018 Q3 25 2.74 M $48.0 M
2018 Q2 17 2.39 M $35.5 M
2018 Q1 12 3.08 M $31.0 M
2017 Q4 13 3.24 M $34.0 M
2017 Q3 13 3.14 M $31.3 M